TipRanks
Terragen Holdings Ltd (AU:TGH)
ASX:TGH
Australian Market
Want to see AU:TGH full AI Analyst Report?

Terragen Holdings Ltd (TGH) AI Stock Analysis

1 Followers

Top Page

AU:TGH

Terragen Holdings Ltd

(Sydney:TGH)

Select Model
Select Model
Select Model
Underperform 40 (OpenAI - Gpt-5.6Sol)
Rating:40Underperform
Price Target:
AU$0.01
▼(-40.00% Downside)
Action:Downgraded
Date:10/27/26
The score is driven primarily by weak financial performance, with persistent losses and ongoing cash burn outweighing the benefit of low leverage. Technical indicators also point to a sustained downtrend (price below key moving averages and negative MACD). Valuation provides limited support due to a negative P/E and no dividend yield data.
Positive Factors
Low Leverage
Very low leverage reduces refinancing pressure and preserves financial flexibility relative to a more indebted capital structure. This gives Terragen greater capacity to manage ongoing operating challenges and potentially fund activities without relying heavily on additional borrowing.
Negative Factors
Persistent Losses and Deeply Negative Margins
Extremely negative operating and net margins show that the current cost structure is far too large for the revenue base. Persistent losses weaken the prospect of near-term self-sustaining profitability and can continue eroding shareholder value unless operating efficiency improves materially.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
Very low leverage reduces refinancing pressure and preserves financial flexibility relative to a more indebted capital structure. This gives Terragen greater capacity to manage ongoing operating challenges and potentially fund activities without relying heavily on additional borrowing.
Read all positive factors

Terragen Holdings Ltd (TGH) vs. iShares MSCI Australia ETF (EWA)

Terragen Holdings Ltd Business Overview & Revenue Model

Company Description
Based in Coolum Beach, Australia, and founded in 1996, Terragen Holdings Limited specializes in the innovation, production, and commercialization of biological products for the agricultural sector. The company distributes its solutions throughout ...

Terragen Holdings Ltd Financial Statement Overview

Summary
Overall fundamentals are weak. The income statement shows persistent and worsening losses with deeply negative operating and net margins despite a positive but deteriorating gross margin. Cash flow is a major concern with ongoing and worsening negative operating cash flow and consistently negative free cash flow. The main offset is a comparatively healthier balance sheet with low leverage, but negative ROE underscores continued pressure on equity.
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
14
Very Negative
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue1.43M1.62M2.14M3.28M2.89M
Gross Profit524.91K792.23K2.06M3.21M2.62M
EBITDA-4.09M-4.53M-3.50M-3.46M-5.67M
Net Income-3.75M-3.72M-3.01M-3.23M-5.41M
Balance Sheet
Total Assets10.59M8.12M6.95M6.35M9.22M
Cash, Cash Equivalents and Short-Term Investments7.36M4.81M4.54M4.17M6.67M
Total Debt275.57K735.45K542.23K239.37K332.26K
Total Liabilities1.09M1.55M1.63M1.27M1.46M
Stockholders Equity9.50M6.57M5.32M5.08M7.76M
Cash Flow
Free Cash Flow-3.49M-3.03M-2.35M-2.91M-4.97M
Operating Cash Flow-3.38M-3.03M-2.32M-2.81M-4.80M
Investing Cash Flow-176.70K-682.43K-132.93K-35.20K-118.20K
Financing Cash Flow6.12M3.87M2.82M351.00K-52.70K

Terragen Holdings Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.02
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
0.03
Positive
STOCH
-18.18
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TGH, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, above the 50-day MA of 0.02, and above the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 0.03 is Positive, neither overbought nor oversold. The STOCH value of -18.18 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:TGH.

Terragen Holdings Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
50
Neutral
AU$55.23M-19.86-22.21%―-30.52%-19.67%
49
Neutral
AU$1.20B-6.85-7.49%2.02%-1.53%-281.84%
44
Neutral
AU$17.98M-1.94-88.51%―-0.48%-195.74%
41
Neutral
AU$13.65M-7.71-6.36%――96.72%
40
Underperform
AU$10.70M-2.10-52.55%―-11.34%30.34%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:TGH
Terragen Holdings Ltd
0.01
>-0.01
-40.91%
AU:CP8
Canadian Phosphate
0.14
0.08
141.38%
AU:NUF
Nufarm Limited
3.12
0.96
44.44%
AU:AMN
Agrimin Limited
0.04
-0.04
-54.55%
AU:RLF
RLF AgTech Ltd
0.03
-0.05
-63.01%
AU:KM1
Kali Metals Limited
0.08
-0.07
-45.33%

Terragen Holdings Ltd Corporate Events

Terragen Sets Virtual-Only AGM for 27 November 2026
Oct 26, 2026
Terragen Holdings Ltd has scheduled its 2026 Annual General Meeting for 9:00 a.m. Melbourne time on Friday, 27 November 2026. The meeting will be conducted entirely online as a virtual-only event, with shareholders able to participate via the spec...
Terragen discloses final director interest as Michele Allan departs board
Oct 20, 2026
Terragen Holdings Ltd has announced that Dr Michele Allan AO has ceased serving as a director of the company as of 16 October 2026, and lodged a final director’s interest notice with the ASX. The filing details that Dr Allan holds a total of...
Terragen appoints fractional CFO after finance chief resigns
Oct 7, 2026
Terragen Holdings Limited has announced the resignation of Chief Financial Officer and Joint Company Secretary Daniel Pearce, effective immediately, and moved to an outsourced model for financial leadership. The company has engaged Traverse Accoun...
Terragen Sets Date and Nomination Process for 2026 AGM
Oct 2, 2026
Terragen Holdings Limited has scheduled its 2026 Annual General Meeting for Friday, 27 November 2026, with the election of directors to be included as an item of business. The company has outlined the timetable and process for director nominations...
Terragen Details Compliance With ASX Corporate Governance Standards
Aug 25, 2026
Terragen Holdings Limited has detailed its corporate governance practices for the 2025–26 financial year, confirming alignment with the ASX Corporate Governance Council’s latest principles and recommendations. The board emphasises clea...
Terragen Posts Wider Loss as Revenue Falls and Asset Backing Erodes
Aug 25, 2026
Terragen Holdings Limited, an agricultural biotechnology company, develops and markets biological products aimed at improving livestock and crop performance for farmers and agribusiness clients. Operating in a specialised agri-tech niche, the comp...
Terragen targets large-scale cattle probiotics rollout with new feedlot deals
Jul 30, 2026
Terragen Holdings Limited has secured conditional supply agreements that mark its first large-scale commercial deployment of Terragen Probiotic for Ruminants and Great Land Plus into major feedlot operations. The company signed a landmark agreemen...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 27, 2026